Abstract: Embodiments relate to generating and using a customized preflight checklist graphical user interface (GUI) specific to a specified aircraft. A client device may receive a selection of an aircraft to be piloted by a user and retrieves sensor data generated by a sensor of the aircraft. The client device may update a preflight checklist GUI based in part on the sensor data and the aircraft such that the preflight checklist GUI is a customized preflight checklist GUI specific to the aircraft. After determining that a set of preflight checks of the customized preflight checklist GUI are completed, the client device may transmit an authorization to the specified aircraft that authorizes the specified aircraft.

Abstract: The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.

Abstract: The present invention relates to compositions and manufacturing methods of topical adapalene preparations, which include a solvent-lipid complex in order to keep the active pharmaceutical ingredient dissolved in a vehicle whose external or continuous phase is aqueous. Thus, a pleasant non-oily sensation is achieved at the moment of application, while greater retention of the active pharmaceutical ingredient is reached in targeted skin layers, thereby reducing systemic uptake in the blood.

Abstract: The present invention relates to pharmaceutical compositions comprising combinations of amino acids, vitamins, and minerals, which prevent the occurrence of adverse effects associated with prolonged use of glucocorticoids (GCs), especially those of particular relevance due to their high frequency and potential debilitating effect for the patient. These effects are steroid myopathy, hyperglycemia and loss of bone mass.

Abstract: The present invention relates to a pharmaceutical composition containing a combination of vitamins, specific salts of calcium, magnesium, and iron, probiotics and prebiotics, which prevents the occurrence of adverse effects associated with long-term use of proton-pump inhibitors (PPIs). This effect is achieved by restoring all nutrient deficiencies and rectifying the intestinal flora imbalance caused by this type of drugs, particularly in patients with gastroesophageal reflux disease and Zollinger-Ellison syndrome.

Abstract: The present invention relates to pharmaceutical compositions containing a combination of reduced forms of folate, liver protectors, vitamins, and essential or non-essential amino acids, useful in preventing the adverse effects associated with prolonged use of dihydrofolate reductase inhibitors.

Abstract: The present invention relates to a pharmaceutical composition containing a combination of vitamins, specific salts of calcium, magnesium, and iron, probiotics and prebiotics, which prevents the occurrence of adverse effects associated with long-term use of proton-pump inhibitors (PPIs). This effect is achieved by restoring all nutrient deficiencies and rectifying the intestinal flora imbalance caused by this type of drugs, particularly in patients with gastroesophageal reflux disease and Zollinger-Ellison syndrome.

Abstract: The present invention provides compositions and methods for treating pain by the administration of analgesics. The analgesics are encapsulated in diacylglycerol-polyethyleneglycol (DAG-PEG) liposomes and delivered sublingually as aerosols.